Literature DB >> 23732901

HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey.

Yvonne Deleré1, Merle M Böhmer, Dietmar Walter, Ole Wichmann.   

Abstract

OBJECTIVE: Routine immunization of adolescent girls aged 12-17 y against human papillomavirus (HPV) was recommended in Germany in March 2007. We aimed to assess HPV-vaccine uptake and knowledge about post-vaccination cervical cancer screening and condom use in women aged 18-20 years, three years after adoption of HPV-vaccination into the routine vaccination schedule.
RESULTS: Overall 2,001 females participated in our study. Of these, 49% reported receipt of a complete three-dose course of HPV-vaccines; 11% received 1 or 2 doses. Living in East Germany, high educational status, and interest in health-related issues were independently associated with HPV-vaccination. Misconceptions among survey-participants were rare: Only 8% believed that HPV-vaccination would obviate the need for cervical screening and 1% that condom use would be dispensible after vaccination.
METHODS: In 2010, a nationwide cross-sectional telephone-survey was performed among randomly-selected women aged 18-20 years living in Germany. Telephone interviews were conducted by a large professional market research institute as part of a daily omnibus survey.
CONCLUSION: HPV-vaccination coverage is low in Germany. The results indicate that there is an urgent need for the implementation of a coordinated adolescent vaccination program to facilitate access to vaccination, including balanced information tailored to this age group. Otherwise, the HPV-vaccination effort will fall short of reaching its maximum public health benefit.

Entities:  

Keywords:  Germany; HPV; cross-sectional survey; telephone interview; vaccine uptake

Mesh:

Substances:

Year:  2013        PMID: 23732901      PMCID: PMC3906270          DOI: 10.4161/hv.24904

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  18 in total

1.  HPV infection awareness and self-reported HPV vaccination coverage in female adolescent students in two German cities.

Authors:  F Samkange-Zeeb; L Spallek; S J Klug; H Zeeb
Journal:  J Community Health       Date:  2012-12

2.  Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status.

Authors:  Delphine Lutringer-Magnin; Julie Kalecinski; Claire Cropet; Giovanna Barone; Vincent Ronin; Véronique Régnier; Yann Leocmach; Anne-Carole Jacquard; Philippe Vanhems; Franck Chauvin; Christine Lasset
Journal:  Eur J Public Health       Date:  2013-02-21       Impact factor: 3.367

3.  Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010.

Authors:  Paul M Darden; David M Thompson; James R Roberts; Jessica J Hale; Charlene Pope; Monique Naifeh; Robert M Jacobson
Journal:  Pediatrics       Date:  2013-03-18       Impact factor: 7.124

4.  What affects human papillomavirus vaccination rates? A qualitative analysis of providers' perceptions.

Authors:  Rebecca B Perkins; Jack A Clark
Journal:  Womens Health Issues       Date:  2012-05-18

5.  Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited.

Authors:  Susan T Vadaparampil; Jessica A Kahn; Daniel Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard Roetzheim; Karen Bruder; Teri L Malo; Tina Proveaux; Xiuhua Zhao; Neal Halsey; Anna R Giuliano
Journal:  Vaccine       Date:  2011-09-14       Impact factor: 3.641

6.  Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010.

Authors:  Petra Stöcker; Manuel Dehnert; Melanie Schuster; Ole Wichmann; Yvonne Deleré
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

7.  Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.

Authors:  Robert A Bednarczyk; Guthrie S Birkhead; Dale L Morse; Helene Doleyres; Louise-Anne McNutt
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

8.  HPV vaccination in France: uptake, costs and issues for the National Health Insurance.

Authors:  Jean-Paul Fagot; Aurélie Boutrelle; Philippe Ricordeau; Alain Weill; Hubert Allemand
Journal:  Vaccine       Date:  2011-03-05       Impact factor: 3.641

Review 9.  The epidemiology of human papillomavirus infections.

Authors:  Janet G Baseman; Laura A Koutsky
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

10.  Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds.

Authors:  Robert A Bednarczyk; Robert Davis; Kevin Ault; Walter Orenstein; Saad B Omer
Journal:  Pediatrics       Date:  2012-10-15       Impact factor: 7.124

View more
  9 in total

1.  HPV vaccine uptake after introduction of the vaccine in Germany: an analysis of administrative data.

Authors:  Sabrina Hense; Kathrin Hillebrand; Johannes Horn; Rafael Mikolajczyk; Renate Schulze-Rath; Edeltraut Garbe
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

2.  Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site.

Authors:  Cornelius Remschmidt; Dietmar Walter; Patrick Schmich; Matthias Wetzstein; Yvonne Deleré; Ole Wichmann
Journal:  Hum Vaccin Immunother       Date:  2014-10-30       Impact factor: 3.452

3.  Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.

Authors:  Cornelius Remschmidt; Michaela Fesenfeld; Andreas M Kaufmann; Yvonne Deleré
Journal:  BMC Public Health       Date:  2014-12-05       Impact factor: 3.295

4.  Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.

Authors:  Barbara Romanowski; Tino F Schwarz; Linda Ferguson; Klaus Peters; Marc Dionne; Ulrich Behre; Karin Schulze; Peter Hillemanns; Pemmaraju Suryakiran; Florence Thomas; Frank Struyf
Journal:  Hum Vaccin Immunother       Date:  2015-07-15       Impact factor: 3.452

5.  Factors influencing uptake of HPV vaccination among girls in Germany.

Authors:  Stefanie Schülein; Katherine J Taylor; Jochem König; Matthias Claus; Maria Blettner; Stefanie J Klug
Journal:  BMC Public Health       Date:  2016-09-20       Impact factor: 3.295

6.  Cost-effectiveness of human papillomavirus vaccination in Germany.

Authors:  Oliver Damm; Johannes Horn; Rafael T Mikolajczyk; Mirjam E E Kretzschmar; Andreas M Kaufmann; Yvonne Deleré; Bernhard Ultsch; Ole Wichmann; Alexander Krämer; Wolfgang Greiner
Journal:  Cost Eff Resour Alloc       Date:  2017-09-04

7.  Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.

Authors:  Kathrin Thöne; Johannes Horn; Rafael Mikolajczyk
Journal:  BMC Infect Dis       Date:  2017-08-14       Impact factor: 3.090

Review 8.  Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Authors:  Marc Arbyn; Lan Xu; Cindy Simoens; Pierre Pl Martin-Hirsch
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09

9.  Current views and advances on Paediatric Virology: An update for paediatric trainees.

Authors:  Ioannis N Mammas; Anne Greenough; Maria Theodoridou; Anna Kramvis; Iliana Christaki; Chryssie Koutsaftiki; Maria Koutsaki; Dimitra M Portaliou; Georgia Kostagianni; Paraskevi Panagopoulou; George Sourvinos; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2015-11-24       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.